Healthcare can become more resilient, agile, and innovative by shifting to digitally enabled business models with data at the core. The COVID-19 pandemic, and not the...
The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout...
Anyone thinking that 2020 might travel down a predictable path for the biopharma sector was swiftly disabused of this view in the opening weeks of the...
Venture capital dollars flowing to US digital health continued to surge in Q3 2020. One thing is for sure—2020 will be the largest funding year ever...
Related Post The need for speed in the post-COVID-19 era— and h... When will the COVID-19 pandemic end? Reimagining MedTech for a COVID-19 world Digital health...
Survey findings confirm that organizational speed is an essential ingredient for out performance in times of unprecedented change, and point to three ways companies can gain...
In 1920, a world wearied by the First World War and sickened by the 1918 flu pandemic desperately sought to move past the struggles and tragedies...
COVID-19 is creating unprecedented challenges for the medtech sector. Companies should consider stress-testing operating models to strengthen crisis resilience and the longer-term path to recovery.
The global pandemic has spurred a massive innovation effort from companies, governments, universities and individuals. Robots are disinfecting cities, cooking hospital food and delivering packages. Smart...
With this survey, we sought to understand how healthcare provider operations and needs have changed during COVID-19, and which of these changes will have long-lasting implications...
Health care stakeholders need to invest in value-based care, innovative care delivery models, advanced digital technologies, data interoperability, and alternative employment models to prepare for these...
Copyright © 2024 Medical Buyer